We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$6.95B
AUM Growth
+$4.09B
Cap. Flow
+$4.07B
Cap. Flow %
58.57%
Top 10 Hldgs %
14.97%
Holding
3,185
New
296
Increased
2,639
Reduced
104
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 7.94%
2 Financials 5.91%
3 Healthcare 3.94%
4 Industrials 3.22%
5 Consumer Discretionary 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HITI
2976
High Tide
HITI
$202M
$1.95K ﹤0.01%
1,034
+517
+100% +$1.36K
DNN icon
2977
Denison Mines
DNN
$2.91B
$1.95K ﹤0.01%
1,500
+1,000
+200% +$1.67K
IGPT icon
2978
Invesco AI and Next Gen Software ETF
IGPT
$1.21B
$1.94K ﹤0.01%
48
+24
+100% +$1.09K
BRBR icon
2979
BellRing Brands
BRBR
$1.34B
$1.94K ﹤0.01%
+26
New +$1.91K
LBRT icon
2980
Liberty Energy
LBRT
$3.25B
$1.93K ﹤0.01%
+122
New +$2.19K
INN
2981
Summit Hotel Properties
INN
$700M
$1.93K ﹤0.01%
+178
New +$1.13K
CTOS icon
2982
Custom Truck One Source
CTOS
$2.37B
$1.91K ﹤0.01%
151
FDIS icon
2983
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.74B
$1.86K ﹤0.01%
+22
New +$2.07K
ERIC icon
2984
Ericsson
ERIC
$33.3B
$1.85K ﹤0.01%
119
-2,881
-96% -$23.3K
JNUG icon
2985
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$531M
$1.84K ﹤0.01%
+30
New +$1.48K
AGX icon
2986
Argan
AGX
$8.37B
$1.84K ﹤0.01%
+14
New +$1.95K
MAGN
2987
Magnera Corp
MAGN
$460M
$1.83K ﹤0.01%
101
-35
-26% -$680
SBSW icon
2988
Sibanye-Stillwater
SBSW
$7.53B
$1.83K ﹤0.01%
+400
New +$1.52K
DDD icon
2989
3D Systems Corp
DDD
$613M
$1.82K ﹤0.01%
860
+430
+100% +$1.46K
PDCO
2990
DELISTED
Patterson Companies, Inc.
PDCO
$1.75K ﹤0.01%
+56
New +$1.74K
PTGX icon
2991
Protagonist Therapeutics
PTGX
$9.44B
$1.74K ﹤0.01%
+36
New +$1.51K
CANG
2992
Cango Inc
CANG
$68.5M
$1.71K ﹤0.01%
45
+30
+200% +$1.28K
TDOC icon
2993
Teladoc Health
TDOC
$1.3B
$1.7K ﹤0.01%
214
+109
+104% +$1.1K
TGNA
2994
DELISTED
TEGNA Inc
TGNA
$1.7K ﹤0.01%
93
+49
+111% +$886
APCX
2995
DELISTED
AppTech Payments
APCX
$1.68K ﹤0.01%
4,000
+2,000
+100% +$858
GLSI icon
2996
Greenwich LifeSciences
GLSI
$211M
$1.68K ﹤0.01%
176
+88
+100% +$1.07K
LEG icon
2997
Leggett & Platt
LEG
$1.31B
$1.66K ﹤0.01%
210
-424
-67% -$4.02K
BHVN icon
2998
Biohaven
BHVN
$2.21B
$1.66K ﹤0.01%
69
+46
+200% +$1.62K
CHPT icon
2999
ChargePoint
CHPT
$161M
$1.65K ﹤0.01%
135
+69
+105% +$1.15K
DNUT icon
3000
Krispy Kreme
DNUT
$577M
$1.64K ﹤0.01%
333
+222
+200% +$1.7K

Similar funds

Geneos Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, Geneos Wealth Management held 3,185 positions worth $6.95B, up 143% from $2.86B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geneos Wealth Management deployed $4.07B of net new capital in Q1 2025, opening 296 new positions and adding to 2,639 existing holdings. Its largest new stake was Putnam Focused Large Cap Value ETF: 311,437 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $105M trimmed.

  • Geneos Wealth Management's largest Q1 2025 buy was Putnam Focused Large Cap Value ETF: 311,437 shares worth $11.9M.
  • Geneos Wealth Management added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $135M increase.
  • Geneos Wealth Management's biggest Q1 2025 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $105M.
  • Geneos Wealth Management fully exited iShares MSCI UAE ETF in Q1 2025, selling an estimated $1.8M.
  • Geneos Wealth Management's ten largest holdings make up 15% of its $6.95B portfolio in Q1 2025.
  • Geneos Wealth Management opened 296 new positions and closed 115 in Q1 2025.
  • Geneos Wealth Management's portfolio value rose 143% quarter-over-quarter to $6.95B.

Based on Geneos Wealth Management's 13F filing for Q1 2025, filed 8 May 2025.